Edition:
United Kingdom

Michael Erman

28 Mar 2017

U.S. hospital shares drop as Republicans weigh healthcare repeal

NEW YORK U.S. hospital stocks dropped on Tuesday as Republicans in the U.S. House of Representatives said they were considering a renewed push to repeal and replace Obamacare, after the effort failed last week.

22 Mar 2017

Hospital, Medicaid insurer shares set for volatility as health vote nears

NEW YORK The slumping U.S. healthcare stocks at the center of efforts to dismantle the Affordable Care Act are expected to stay volatile as Republican legislation heads into a vote on Thursday that could signal how protracted their battle to repeal the law will be.

08 Mar 2017

Industry questions higher insurance costs under Republican plan

NEW YORK The House Republican health insurance plan suggests health insurance after Obamacare will be less affordable, investors, insurers and industry sources said on Tuesday, raising questions about future enrollment and insurance company participation.

07 Mar 2017

Industry questions higher insurance costs under Republican plan

NEW YORK, March 7 The House Republican health insurance plan suggests health insurance after Obamacare will be less affordable, investors, insurers and industry sources said on Tuesday, raising questions about future enrollment and insurance company participation.

28 Feb 2017

Tenet CEO welcomes delays in Republican changes to Obamacare

The delays in Republican plans to overhaul Obamacare are helpful to hospital operator Tenet Healthcare Corp , the company's chief executive officer said on Tuesday, as the timeline shifts further out for any changes to government healthcare payments.

28 Feb 2017

Tenet CEO welcomes delays in Republican changes to Obamacare

NEW YORK The delays in Republican plans to overhaul Obamacare are helpful to hospital operator Tenet Healthcare Corp, the company's chief executive officer said on Tuesday, as the timeline shifts further out for any changes to government healthcare payments.

27 Feb 2017

J&J says kept drug price increases below 10 percent since 2012

NEW YORK Johnson & Johnson on Monday said the average list price of its drugs rose less than 10 percent each year since 2012, noting that the net price paid for the drugs, which includes discounts and rebates, was significantly lower.

15 Feb 2017

Anthem sues Cigna to block termination of merger

Anthem Inc on Wednesday won a temporary restraining order that blocks smaller rival Cigna Corp from officially terminating their proposed $54 billion merger, a transaction already rejected by U.S. antitrust regulators.

15 Feb 2017

Anthem sues Cigna to block termination of merger

Anthem Inc on Wednesday won a temporary restraining order that blocks smaller rival Cigna Corp from officially terminating their proposed $54 billion merger, a transaction already rejected by U.S. antitrust regulators. | Video

13 Feb 2017

Allergan to buy fat-fighter Zeltiq Aesthetics for $2.48 billion

Botox maker Allergan Plc <AGN.N,> agreed to pay $2.48 billion in cash for Zeltiq Aesthetics Inc, adding a system that it says helps people slim down by freezing fat away to the company's line-up of aesthetic products.

More From Around the Web

  • Europe
  • U.S.
  • Asia
  • Sectors
Stock Search
FTSE 100 7,373.72 + 30.30 +0.41%
DAX 12,203.00 + 53.58 +0.44%
CAC 40 5,069.04 + 22.84 +0.45%
TR Europe 160.39 -0.52 -0.32%
GBP/USD 1.2425 -0.18%
GBP/EUR 1.1543 +0.28%
EUR/USD 1.0762 -0.46%
Gold 1,252.20 -3.10 -0.25%
Oil 49.32 +0.95 +1.96%
Corn 358.50 +0.75 +0.21%